Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS
· Real-Time Price · USD
3.27
0.07 (2.19%)
At close: Aug 15, 2025, 3:59 PM
3.28
0.46%
After-hours: Aug 15, 2025, 04:10 PM EDT
Alpha Tau Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -32.46M | -31.75M | -29.64M | -27.63M | -28.95M | -29.16M | -25.19M | -22.9M | -16.2M | -33.76M | -63M | -65.17M | -70.16M | -56.12M | -25.91M | -23.54M | -18.57M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 512K | 512K | 1.49M | 1.49M | 1.22M | 1.45M | 1.25M | 1.45M | 1.39M | 1.32M | 571K | 401K | 231K |
Stock-Based Compensation | 9.92M | 9.92M | 7.93M | 9.01M | 7.93M | 7.93M | 6.75M | 10.53M | 8.21M | 10.19M | 4.26M | 4.46M | 3.12M | 1.28M | 635K | 600K | 611K |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | -131.75K | -131.75K | -11.75K | -2.64M | -2.5M | -2.42M | -2.09M | -198.71K | 125.5K | 368K | -17.5K |
Other Non-Cash Items | 22.54M | 21.83M | 21.71M | 18.62M | 21.02M | 21.23M | 18.44M | 12.37M | -9.59M | -826K | 24.74M | 26.91M | 47.61M | 39.61M | 17.39M | 12.59M | 9.02M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -7.86M | -7.86M | 3.25M | 3.25M | 11.11M | 11.11M | 12.17M | 12.17M | 12.17M | 12.17M | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | -76.75K | -76.75K | -2.59M | -2.59M | -2.27M | -2.12M | 1.17M | 503.04K | 588.25K | 771K | 54.5K |
Operating Cash Flow | n/a | n/a | n/a | -3.78K | n/a | n/a | -5.97M | -5.97M | -14.71M | -21.3M | -26.28M | -29.23M | -22.73M | -19.27M | -10.23M | -9.18M | -8.66M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -226K | -226K | -603K | -901K | -3.6M | -4.33M | -4.55M | -4.87M | -3.15M | -3.64M | -3.71M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -30.28M | -30.28M | -30.28M | -30.28M | 275M | 272.98M | 272.98M | -2.02M | -278.03M | -277.02M | -278.04M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 8.03M | 8.03M | 8.03M | 8.03M | 7.57M | 15.14M | 15.14M | 15.14M | 7.57M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 226K | 226K | -91.77M | -91.77M | -69.8M | -69.07M | 25.43M | 25.43M | 6.21M | 8.45M | 950K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -22.26M | -22.26M | -114.64M | -114.93M | 201.6M | 207.15M | 301.43M | 301.12M | 8.6M | 4.81M | -2.76M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -128.65M | -128.65M | -113.83M | -31.85M | 373.35M | 373.35M | 358.56M | 276.57M | 2.47M | 4.92M | 17.11M |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 23.39M | 23.39M | 38.2M | 120.19M | -179.68M | -179.68M | -194.48M | -276.46M | 2.47M | 4.92M | 17.11M |
Net Cash Flow | n/a | n/a | n/a | 1.28M | 1.23M | -3.72M | -99.56M | -100.84M | -187.33M | -107.33M | 11.63M | 5.88M | 92.26M | 12.91M | -6.63M | -8.38M | 2.87M |
Free Cash Flow | n/a | n/a | n/a | -3.78K | n/a | n/a | -6.2M | -6.19M | -15.32M | -22.2M | -29.88M | -33.57M | -27.28M | -24.14M | -13.38M | -12.82M | -12.37M |